Alterations in biliary excretory function by streptozotocin-induced diabetes

Area of Science:

• Pharmacology
• Hepatology
• Endocrinology

Background:

• Insulin-deficient diabetes is a complex metabolic disorder.
• Diabetes can significantly impact physiological functions, including drug metabolism and excretion.
• Understanding hepatic excretory function in diabetes is crucial for drug development and patient management.

Purpose of the Study:

• To investigate the effects of long-term insulin-deficient diabetes on hepatic clearance and biliary excretion of various model substrates.
• To determine how diabetes influences carrier-mediated transport systems in the liver.

Main Methods:

• Streptozotocin-induced diabetes model in male Sprague-Dawley rats.
• Administration of model substrates: phenol red (anionic), procainamide ethobromide (cationic), ouabain (uncharged), and taurocholate (bile acid).
• Measurement of plasma disappearance, biliary excretion, elimination half-life, total clearance, and bile flow rates.

Main Results:

• Diabetic rats showed hyperglycemia, polyuria, polyphagia, polydipsia, and myopathy.
• Clearance of phenol red was increased, with increased glucuronidation.
• Clearance of procainamide ethobromide, ouabain, and taurocholate significantly increased (2-3 fold), primarily due to a 2-5 fold increase in the volume of distribution.
• Bile flow rate increased by 62%, with higher secretion of bile acids, cholesterol, and phospholipids.

Conclusions:

• Long-term insulin-dependent diabetes significantly alters hepatic excretory function in rats.
• Changes in clearance are largely attributed to altered volume of distribution and increased bile flow.
• Diabetes affects the transport and excretion of anionic, cationic, uncharged compounds, and bile acids.